El modelo "BlockBuster"...agotado.
A city analyst argued that ‘For the first time in history, the industry will have negative growth in 2011’ and Bain & Co. consultant Preston Henske stated that ‘the blockbuster business model is irreparably broken’.
This search for the cash cow to carry them through the next decade is no longer a sustainable model: to move forward the industry must become more flexible. The blockbusters that are currently sustaining these large companies are being lost as their patent life expires.When a drug loses patent, sales of blockbuster drugs can often fall by up to 90% within a year through competition from cheaper generic versions.
Blockbuster drugs account for 60% of the $245 billion (circa £136 billion) in sales of the ten leading pharmaceutical companies. The majority of top earning drugs that were patented in the 1990s face expiration within the next few years, and 80 drugs that currently account for about 25% of drug sales will lose their patent between 2007 and 2011.
Between 2008 and 2011 $40 billion (circa £22 billion) in global sales by the top pharmaceutical companies will be lost.
Click sobre imagen paraq ampliar
Ver anteriores...(te interesará)
Entradas
No hay comentarios:
Publicar un comentario